T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease Academic Article uri icon

Overview

MeSH Major

  • CD4-Positive T-Lymphocytes
  • CD8-Positive T-Lymphocytes
  • Coronary Artery Disease
  • Cytomegalovirus Infections
  • Heart Transplantation

abstract

  • The early control of subclinical CMV replication after transplantation by T-cell immunity may limit cardiac allograft rejection and vascular disease. Interventions to increase T-cell immunity might be clinically useful in limiting these adverse viral effects.

publication date

  • October 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.105.607549

PubMed ID

  • 17015794

Additional Document Info

start page

  • 1608

end page

  • 15

volume

  • 114

number

  • 15